As global demand turns kava into pills and energy shots, what does this cost the Pacific?
<p>"If kava is extracted and introduced into another beverage, is it still kava?"</p><p>That's the question Fe'iloakitau Kaho Tevi, Chairman of Tonga’s National Kava Committee, has been posing to Pacific leaders. Today, kava is being rapidly commercialised - squeezed into pills, energy shots, and mocktails around the world, while finding eager new markets closer to home in places like Kiribati and the Solomon Islands.</p><p>That global boom is bringing in big money to local growers, but it's also pushing crops to the brink. Dr Apo Aporosa, a Fijian health scholar at the University of Waikato, says that widespread commercialisation has fuelled a wave of misunderstandings around kava's health implications.</p><p>At the same time, the land itself is under pressure. Kava can take up to five years to mature, and a shift toward monocropping has left crops vulnerable to diseases, while extreme droughts and cyclones ruin harvests.</p><p>As kava crosses borders and becomes a multi-million-dollar global commodity, who gets to control its future? And how do we balance an export boom with protecting a plant so deeply bound to Pacific identity? </p><p>Culture Compass was produced by <a href="https://www.deadsetstudios.com/" target="_blank">Deadset Studios</a> for ABC Radio Australia.</p>
